Dupixent for Atopic Dermatitis. Just Approved in
Post# of 72436
![](/assets/46931549/no_avatar_available_thumb.jpg)
Just Approved in 2017.
$209mm sales for last qtr.
Almost clear to clear in 33% of patients.
Delivery Injection.
ADVERSE REACTIONS: The most common adverse reactions (incidence ≥1%) are injection site reactions, conjunctivitis, blepharitis, oral herpes, keratitis, eye pruritus, other herpes simplex virus infection, and dry eye.
Can't wait to see B in a cream for Atopic Dermatitis.
Looks like the bar for AD is set pretty low....
B is a freaking GOLD mine!
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)